Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1137-2022Class II

progenamatrix Human Keratin Matrix, sterile, Rx, with the following model numbers: (1) PM2012, 12 x 2 cm; (2)...

ProgenaCare / initiated 2022-04-18 / Terminated / root cause: manufacturing process

ProgenaCare began a recall of progenamatrix Human Keratin Matrix, sterile, Rx, with the following model numbers: (1) PM2012, 12 x 2 cm; (2) PM3002, 2 x 2 cm; (3) PM3004, 4 x 4 cm; PM3006, 6... on . FDA classified it as Class II and gives the reason as "Inner pouch seal may be inadequate resulting in lack of sterility". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1137-2022
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
ProgenaCare
Product
progenamatrix Human Keratin Matrix, sterile, Rx, with the following model numbers: (1) PM2012, 12 x 2 cm; (2) PM3002, 2 x 2 cm; (3) PM3004, 4 x 4 cm; PM3006, 6 x 6 cm; and PM3010, 10 x 10 cm.
Product code
KGN Wound Dressing With Animal-Derived Material(S)
Reason for recall
Inner pouch seal may be inadequate resulting in lack of sterility.
Root cause tag
manufacturing process
FDA root cause
Employee error
Action
The recalling firm issued letters dated 4/18/2022 via FedEx on 4/18/2022 for all but one consignee, who was hand-delivered the letter on 4/20/2022. The letter identified the product and requested the consignee immediately check their inventory for the affected product and quarantine it prior to return. The consignee is requested to forward the recall notification to any customers who were distributed the product and request it be returned. The consignee was requested to contact the recalling firm by email no later than 4/30/2022 to confirm receipt of the letter and to obtain a Return Materials Authorization for any units in their inventory. A reply card was also enclosed should the consignee rather mail their response to the recalling firm. The reply card asked if they have any recalled product in inventory, have they distributed any of it, and requests their customers are notified of the recall.
Quantity in commerce
547 packages
Distribution
US Nationwide distribution in the states of AL, GA, FL, TN, and TX. There was no foreign/military/government distribution.
Product codes and lots
(1) Model PM2012, lot #02SEP21-001, exp. 4/9/2024; lot #29SEP21-001, exp. 4/9/2024. (2) Model PM3002, lot #28OCT21-001, exp. 3/7/2024. (3) Model PM3004, lot #02DEC21-001, exp. 10/1/2023; lot #02SEP21-002, exp. 10/1/2023; lot #14OCT21-001, exp. 10/1/2023; and 23NOV21-001, exp. 10/1/2023. (4) Model PM3006, lot #02SEP21-003, exp. 10/1/2023; lot #03DEC21-001, exp. 10/1/2023; lot #14OCT21-002, exp. 10/1/2023; and lot #23NOV21-002, exp. 10/1/2023. (5) Model PM3010, lot #13JUL21-001, exp. 10/1/2023; and lot #15JUL21-002, exp. 3/6/2024.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1137-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1137-2022Class IITerminatedVoluntary: Firm initiated